Case number 2018-2126
Eli Lilly and Company v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ELI LILLY AND COMPANY v. HOSPIRA, INC. [OPINION - PRECEDENTIAL] [precedential] (0) |
| Jun 15, 2020 | 73 | The petition for writ of certiorari, [19-1058], filed on 02/24/2020, was Denied on 06/15/2020. [701229] [JAB] [Entered: 06/15/2020 03:38 PM] (1) |
| Feb 27, 2020 | 72 | Petition for writ of Certiorari filed on 02/24/2020, and placed on the docket 02/26/2020, in the Supreme Court of the United States. Supreme Court #: 19-1058, Hospira, Inc. v. Eli Lilly and Company. [674927] [JAB] [Entered: 02/27/2020 03:29 PM] (1) |
| Feb 4, 2020 | 71 | Notice from the Supreme Court of the United States: The application for an extension of time within which to file a petition for a writ of certiorari in the above-entitled case has been presented to The Chief Justice, who on January 28, 2020, extended the time to and including February 24, 2020. [668658] [JAB] [Entered: 02/05/2020 01:48 PM] (3) |
| Nov 15, 2019 | 70 | Mandate issued to the United States District Court for the Southern District of Indiana. Service as of this date by the Clerk of Court. [649601] [18-2126, 18-2127] [JAB] [Entered: 11/15/2019 10:42 AM] (1) |
| Nov 8, 2019 | 69 | ORDER filed denying [52] petition for en banc rehearing filed by Hospira, Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [648073] [JAB] [Entered: 11/08/2019 11:11 AM] (2) |
| Oct 25, 2019 | 68 | 18 paper copies of the response [67] received from Appellee Eli Lilly and Company. [644737] [JAB] [Entered: 10/25/2019 12:01 PM] (0) |
| Oct 23, 2019 | 67 | RESPONSE of Appellee Eli Lilly and Company to the petition for en banc rehearing [52] filed by Appellant Hospira, Inc.. Service: 10/23/2019 by email. [644298] [18-2126] [Adam Perlman] [Entered: 10/23/2019 07:14 PM] (25) |
| Oct 9, 2019 | 66 | The court invites a response from Appellee Eli Lilly and Company to the petition for en banc rehearing filed by Appellant in 18-2126. The response is due on or before 10/23/2019. [641258] [JAB] [Entered: 10/09/2019 10:30 AM] (1) |
| Sep 27, 2019 | 65 | 18 paper copies of the Corrected Amicus Brief [64] received from Amicus Curiae Association for Accessible Medicines. [638827] [CJF] [Entered: 09/27/2019 03:02 PM] (0) |
| Sep 26, 2019 | 64 | CORRECTED AMICUS BRIEF FILED on Petition for Association for Accessible Medicines. Pages: 12. Service: 09/25/2019 by email. The filer is directed to submit the appropriate number of copies within two days. [638408] [JAB] [Entered: 09/26/2019 10:58 AM] (19) |
| Sep 26, 2019 | 63 | ORDER filed granting motion leave to file amicus brief on en banc or rehearing petition [58] in 18-2126, granting motion leave to file amicus brief on en banc or rehearing petition [637625-2] in 18-2128. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [638407] [18-2126, 18-2128] [JAB] [Entered: 09/26/2019 10:55 AM] (2) |
| Sep 25, 2019 | 62 | CORRECTED AMICUS CURIAE BRIEF from Association for Accessible Medicines. Service: 09/25/2019 by email. [638189] [18-2126] [Brian Burgess] [Entered: 09/25/2019 01:50 PM] (19) |
| Sep 25, 2019 | 61 | Entry of appearance for Jeffrey Francer as of counsel for Association for Accessible Medicines. Service: 09/25/2019 by email. [638174] [18-2126] [Jeffrey Francer] [Entered: 09/25/2019 01:37 PM] (2) |
| Sep 25, 2019 | 60 | NOTICE OF NON-COMPLIANCE: The submission of Association for Accessible Medicines, Amicus Curiae Brief [59], is not in compliance with the rules of this court (see attached). Compliant document due on 10/02/2019. Service as of this date by the Clerk of Court. [637942] [JAB] [Entered: 09/25/2019 07:57 AM] (1) |
| Sep 23, 2019 | 59 | FILED from Association for Accessible Medicines Title: AMICUS CURIAE BRIEF. Service: 09/23/2019 by email. [637624] [18-2126] This document is non-compliant. See Doc. No. [60]. [Brian Burgess] [Entered: 09/23/2019 08:14 PM] (19) |
| Sep 23, 2019 | 58 | MOTION of Association for Accessible Medicines for leave to file amicus brief in support of Appellant on petition for en banc rehearing [52] [Consent: unopposed]. Service: 09/23/2019 by email. [637622] [18-2126] [Brian Burgess] [Entered: 09/23/2019 08:10 PM] (6) |
| Sep 23, 2019 | 57 | Entry of appearance for Brian Burgess as of counsel for Association for Accessible Medicines. Service: 09/23/2019 by email. [637620] [18-2126] [Brian Burgess] [Entered: 09/23/2019 07:43 PM] (2) |
| Sep 23, 2019 | 56 | Entry of appearance for William M. Jay as principal counsel for Association for Accessible Medicines. Service: 09/23/2019 by email. [637618] [18-2126] [William Jay] [Entered: 09/23/2019 07:35 PM] (2) |
| Sep 23, 2019 | 55 | **TEXT ONLY** ORDER granting motion to withdraw attorney Galina I. Fomenkova [54] filed by Appellee Eli Lilly and Company. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [637261] [JAB] [Entered: 09/23/2019 08:11 AM] (0) |
| Sep 20, 2019 | 54 | MOTION of Appellee Eli Lilly and Company to withdraw counsel Galina I. Fomenkova [Consent: unopposed]. Service: 09/20/2019 by email. [637136] [18-2126] [Andrew Lemens] [Entered: 09/20/2019 03:42 PM] (5) |
| Sep 10, 2019 | 53 | 18 paper copies of the petition for en banc rehearing [52] received from Hospira, Inc. [634604] [MJL] [Entered: 09/11/2019 11:24 AM] (0) |
| Sep 9, 2019 | 52 | Petition for en banc rehearing filed by Appellant Hospira, Inc.. Service: 09/09/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 09/11/2019 [634113] [18-2126] [Bradford Lyerla] [Entered: 09/09/2019 04:01 PM] (56) |
| Aug 9, 2019 | 51 | JUDGMENT. AFFIRMED-IN-PART AND REVERSED-IN-PART. Terminated on the merits after oral argument. COSTS: Each side bears its own costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [627173] [18-2126, 18-2127] [JAB] [Entered: 08/09/2019 09:57 AM] (1) |
| Aug 9, 2019 | 50 | OPINION filed for the court by Lourie, Circuit Judge; Moore, Circuit Judge and Taranto, Circuit Judge. Precedential Opinion. [627172] [18-2126, 18-2127, 18-2128] [JAB] [Entered: 08/09/2019 09:56 AM] (26) |
| Jun 3, 2019 | 49 | Submitted after ORAL ARGUMENT by Bradford Peter Lyerla for Hospira, Inc. and Adam Lawrence Perlman for Eli Lilly and Company. Panel: Judge: Lourie , Judge: Moore , Judge: Taranto. [610955] [JAB] [Entered: 06/03/2019 12:51 PM] (0) |
| May 13, 2019 | 48 | Response to notice of oral argument from the Appellant Hospira, Inc.. [606788] [18-2126] [Bradford Lyerla] [Entered: 05/13/2019 10:40 AM] (3) |
| Apr 22, 2019 | 47 | Response to notice of oral argument from the Appellee Eli Lilly and Company. [602080] [18-2126] [Adam Perlman] [Entered: 04/22/2019 04:07 PM] (3) |
| Apr 22, 2019 | 46 | NOTICE OF ORAL ARGUMENT. Panel: 1906B. Case scheduled Jun 03, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 05/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [601848] [JAB] [Entered: 04/22/2019 11:38 AM] (2) |
| Apr 10, 2019 | 45 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Hospira, Inc.. Service: 04/10/2019 by email. [598890] [18-2126] [Sara Horton] [Entered: 04/10/2019 09:56 AM] (16) |
| Jan 16, 2019 | 44 | Notice from Appellant Hospira, Inc. regarding conflicts with oral argument. Service: 01/16/2019 by email. [578571] [18-2126] [Bradford Lyerla] [Entered: 01/16/2019 01:04 PM] (3) |
| Jan 11, 2019 | 43 | 6 paper copies of the Reply Brief [30] received from Appellant Hospira, Inc.. [577767] [CJF] [Entered: 01/11/2019 03:36 PM] (0) |
| Jan 11, 2019 | 42 | 6 paper copies of the Corrected Confidential Joint Appendix Brief [37] received from Appellant Hospira, Inc. and Appellee Eli Lilly and Company. [577765] [CJF] [Entered: 01/11/2019 03:30 PM] (0) |
| Jan 11, 2019 | 41 | Notice from Appellee Eli Lilly and Company regarding conflicts with oral argument. Service: 01/11/2019 by email. [577750] [18-2126] [Adam Perlman] [Entered: 01/11/2019 03:00 PM] (3) |
| Jan 11, 2019 | 40 | 7 paper copies of the Opening Response Brief [28] received from Appellee Eli Lilly and Company. [577748] [CJF] [Entered: 01/11/2019 02:55 PM] (0) |
| Jan 10, 2019 | 38 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [577213] [JAL] [Entered: 01/10/2019 10:01 AM] (0) |
| Jan 10, 2019 | 39 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 01/17/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [577215] [JAL] [Entered: 01/10/2019 10:02 AM] (1) |
| Jan 9, 2019 | 37 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Hospira, Inc. and Appellee Eli Lilly and Company. Number of Pages: 446. Service: 01/09/2019 by US mail. [577050]--[Edited 01/10/2019 by JAL - Compliance review complete] [Bradford Lyerla] [Entered: 01/09/2019 03:17 PM] (0) |
| Jan 9, 2019 | 36 | MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Appellant Hospira, Inc. and Appellee Eli Lilly and Company. Number of Pages: 446. Service: 01/09/2019 by email. [577047] --[Edited 01/10/2019 by JAL - Compliance review complete] [Bradford Lyerla] [Entered: 01/09/2019 03:14 PM] (446) |
| Jan 4, 2019 | 35 | NOTICE OF NON-COMPLIANCE: The submissions of Appellant Hospira, Inc. and Appellee Eli Lilly and Company, Joint Appendix, Confidential Joint Appendix [31], [32], are not in compliance with the rules of this court (see attached). Compliant documents due on 01/11/2019. Service as of this date by the Clerk of Court.[575867] [JAL] [Entered: 01/04/2019 09:30 AM] (2) |
| Dec 27, 2018 | 34 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Eli Lilly and Company and Appellant Hospira, Inc.. Service: 12/27/2018 by email. [574817] [18-2126] [Bradford Lyerla] [Entered: 12/27/2018 03:47 PM] (3) |
| Dec 27, 2018 | 33 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Hospira, Inc.. Service: 12/27/2018 by email. [574816] [18-2126] [Bradford Lyerla] [Entered: 12/27/2018 03:45 PM] (3) |
| Dec 27, 2018 | 32 | FILED from Appellee Eli Lilly and Company and Appellant Hospira, Inc.. Title: CONFIDENTIAL JOINT APPENDIX. Service: 12/27/2018 by email. (PENDING COMPLIANCE REVIEW) [574807] [18-2126] This document is non-compliant. See Doc No.[35] [Bradford Lyerla] [Entered: 12/27/2018 03:30 PM] (0) |
| Dec 27, 2018 | 31 | FILED from Appellee Eli Lilly and Company and Appellant Hospira, Inc.. Title: JOINT APPENDIX. Service: 12/27/2018 by email. (PENDING COMPLIANCE REVIEW) [574800] [18-2126] This document is non-compliant. See Doc No.[35] [Bradford Lyerla] [Entered: 12/27/2018 03:21 PM] (434) |
| Dec 20, 2018 | 30 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Hospira, Inc. Number of Pages: 32. Service: 12/20/2018 by email. [573663] --[Edited 01/03/2019 by JAL - Compliance review complete] [Bradford Lyerla] [Entered: 12/20/2018 03:42 PM] (40) |
| Nov 21, 2018 | 29 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellant Hospira, Inc. reply brief is due 12/27/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [567052] [JB] [Entered: 11/21/2018 10:03 AM] (0) |
| Nov 15, 2018 | 27 | MOTION of Appellant Hospira, Inc. to extend the time to 12/27/2018 to file the Reply Brief. [Consent: unopposed]. Service: 11/15/2018 by email. [565322] [18-2126] [Bradford Lyerla] [Entered: 11/15/2018 01:17 PM] (9) |
| Nov 13, 2018 | 28 | BRIEF FILED for Appellee Eli Lilly and Company [26]. Number of Pages: 70. Service: 11/13/2018 by email. Appellant Hospira, Inc. reply brief is due 11/27/2018. [567050] [JB] [Entered: 11/21/2018 09:59 AM] (81) |
| Nov 13, 2018 | 26 | TENDERED from Appellee Eli Lilly and Company. Title: RESPONSE BRIEF. Service: 11/13/2018 by email. [564664] [18-2126] [Adam Perlman] [Entered: 11/13/2018 08:52 PM] (81) |
| Sep 12, 2018 | 25 | 6 paper copies of the Opening Brief [23] received from Appellant Hospira, Inc.. [549239] [CJF] [Entered: 09/12/2018 03:38 PM] (0) |
| Sep 7, 2018 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellee Eli Lilly and Company. Appellee Eli Lilly and Company brief is due by 11/13/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [547889] [CMP] [Entered: 09/07/2018 10:39 AM] (0) |
| Sep 4, 2018 | 23 | BRIEF FILED for Appellant Hospira, Inc. [22]. Number of Pages: 65. Service: 09/04/2018 by email. The paper copies of the brief should be received by the court on or before 09/14/2018. Appellee Eli Lilly and Company brief is due 10/15/2018. [547886] [CMP] [Entered: 09/07/2018 10:36 AM] (99) |
| Sep 4, 2018 | 22 | TENDERED from Appellant Hospira, Inc.. Title: OPENING BRIEF. Service: 09/04/2018 by email. [547190] [18-2126] [Bradford Lyerla] [Entered: 09/04/2018 09:36 PM] (99) |
| Aug 30, 2018 | 21 | MOTION of Appellee Eli Lilly and Company to extend the time to 11/13/2018 to file the Appellee's Initial Brief. [Consent: unopposed]. Service: 08/30/2018 by email. [546548] [18-2126] [Adam Perlman] [Entered: 08/30/2018 05:30 PM] (8) |
| Aug 20, 2018 | 20 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [544093] [CMP] [Entered: 08/20/2018 02:47 PM] (0) |
| Aug 7, 2018 | 19 | Entry of appearance for Dov P. Grossman as of counsel for Appellee Eli Lilly and Company. Service: 08/07/2018 by email. [541371] [18-2126] [Dov Grossman] [Entered: 08/07/2018 05:53 PM] (2) |
| Aug 7, 2018 | 18 | ORDER filed. Appeal No. 2018-2128 is reactivated. Dr. Reddy's opening brief is due no later than 60 days from the date of filing of this order. The above-captioned appeals shall be considered companion cases and assigned to the same merits panel. Service: 08/07/2018 by clerk. [541325] [18-2128, 18-2126] [LMS] [Entered: 08/07/2018 03:28 PM] (2) |
| Jul 31, 2018 | 17 | Entry of appearance for James P. Leeds as of counsel for Appellee Eli Lilly and Company. Service: 07/31/2018 by email. [539881] [18-2126] [James Leeds] [Entered: 07/31/2018 05:12 PM] (2) |
| Jul 26, 2018 | 16 | Transcript Purchase Order Form for the Appellant Hospira, Inc. indicating that a transcript is already on file. Service: 07/26/2018 by email. [538818] [18-2126] [Bradford Lyerla] [Entered: 07/26/2018 03:27 PM] (1) |
| Jul 26, 2018 | 15 | Entry of appearance for Yusuf Esat as of counsel for Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538812] [18-2126] [Yusuf Esat] [Entered: 07/26/2018 03:21 PM] (2) |
| Jul 26, 2018 | 14 | Entry of appearance for Sara T. Horton as of counsel for Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538807] [18-2126] [Sara Horton] [Entered: 07/26/2018 03:16 PM] (2) |
| Jul 26, 2018 | 13 | Entry of appearance for Adam G. Unikowsky as of counsel for Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538804] [18-2126] [Adam Unikowsky] [Entered: 07/26/2018 03:10 PM] (2) |
| Jul 26, 2018 | 12 | Docketing Statement for the Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538800] [18-2126] [Bradford Lyerla] [Entered: 07/26/2018 03:03 PM] (3) |
| Jul 26, 2018 | 11 | Certificate of Interest for the Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538799] [18-2126] [Bradford Lyerla] [Entered: 07/26/2018 02:59 PM] (3) |
| Jul 26, 2018 | 10 | Entry of appearance for Bradford P. Lyerla as principal counsel for Appellant Hospira, Inc.. Service: 07/26/2018 by email. [538793] [18-2126] [Bradford Lyerla] [Entered: 07/26/2018 02:50 PM] (2) |
| Jul 20, 2018 | 9 | Entry of appearance for Andrew P. Lemens as of counsel for Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537521] [18-2126] [Andrew Lemens] [Entered: 07/20/2018 05:21 PM] (2) |
| Jul 20, 2018 | 8 | Entry of appearance for Charles L. McCloud as of counsel for Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537518] [18-2126] [Charles McCloud] [Entered: 07/20/2018 05:18 PM] (2) |
| Jul 20, 2018 | 7 | Entry of appearance for Galina I. Fomenkova as of counsel for Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537515] [18-2126] [Galina Fomenkova] [Entered: 07/20/2018 05:14 PM] (2) |
| Jul 20, 2018 | 6 | Entry of appearance for David M. Krinsky as of counsel for Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537512] [18-2126] [David Krinsky] [Entered: 07/20/2018 05:09 PM] (2) |
| Jul 20, 2018 | 5 | Docketing Statement for the Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537490] [18-2126] [Adam Perlman] [Entered: 07/20/2018 04:49 PM] (3) |
| Jul 20, 2018 | 4 | Certificate of Interest for the Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537487] [18-2126] [Adam Perlman] [Entered: 07/20/2018 04:46 PM] (4) |
| Jul 20, 2018 | 3 | Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly and Company. Service: 07/20/2018 by email. [537484] [18-2126] [Adam Perlman] [Entered: 07/20/2018 04:43 PM] (2) |
| Jul 6, 2018 | 2 | Note to file: The following cases are associated: 18-2126 Lead with 18-2127 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [533994] [18-2126, 18-2127] [CMP] [Entered: 07/06/2018 10:26 AM] (0) |
| Jul 6, 2018 | 1 | Appeal docketed. Received: 06/28/2018. [533979]Entry of Appearance due 07/20/2018. Certificate of Interest is due on 07/20/2018. Docketing Statement due 07/20/2018. Appellant's brief is due 09/04/2018. [CMP] [Entered: 07/06/2018 09:32 AM] (70) |
